Per-Protocol Analyses of Pragmatic Trials.

Pragmatic trials are designed to address real-world questions about care options. This article addresses issues that may arise from per-protocol and intention-to-treat analyses of such trials, outlines alternative analytic approaches, and provides guidance on how to choose among them.

[1]  Miguel A. Hernán,et al.  Bounding the per-protocol effect in randomized trials: an application to colorectal cancer screening , 2015, Trials.

[2]  S. Cole,et al.  The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial. , 2016, AIDS.

[3]  M. Hernán,et al.  Beyond the intention-to-treat in comparative effectiveness research , 2012, Clinical trials.

[4]  E. Goetghebeur,et al.  Beyond intention to treat. , 2002, Epidemiologic reviews.

[5]  Sander Greenland,et al.  An introduction to instrumental variables for epidemiologists. , 2018, International journal of epidemiology.

[6]  J. Robins,et al.  Doubly Robust Estimation in Missing Data and Causal Inference Models , 2005, Biometrics.

[7]  J M Robins,et al.  Correction for non-compliance in equivalence trials. , 1998, Statistics in medicine.

[8]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[9]  Sandeep K. Gupta,et al.  Intention-to-treat concept: A review , 2011, Perspectives in clinical research.

[10]  J. Robins,et al.  Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests , 2000, Biometrics.

[11]  S. Cole,et al.  Effect of acyclovir on herpetic ocular recurrence using a structural nested model. , 2005, Contemporary clinical trials.

[12]  J. Urquhart,et al.  Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. , 2012, Annual review of pharmacology and toxicology.

[13]  J. Pearl,et al.  Causal inference , 2011, Twenty-one Mental Models That Can Change Policing.

[14]  M. J. Laan,et al.  Targeted Learning: Causal Inference for Observational and Experimental Data , 2011 .

[15]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[16]  S. Normand,et al.  Intent-to-Treat vs. Non-Intent-to-Treat Analyses under Treatment Non-Adherence in Mental Health Randomized Trials. , 2008, Psychiatric annals.

[17]  J. Ioannidis.  Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.

[18]  M. Robins James,et al.  Estimation of the causal effects of time-varying exposures , 2008 .

[19]  J. Robins,et al.  Instruments for Causal Inference: An Epidemiologist's Dream? , 2006, Epidemiology.

[20]  T. Shakespeare,et al.  Observational Studies , 2003 .

[21]  Judea Pearl,et al.  Causal Inference , 2010 .

[22]  Haitao Chu,et al.  The per-protocol effect of immediate versus deferred antiretroviral therapy initiation , 2016, AIDS.

[23]  M. Hernán,et al.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. , 2014, JAMA.

[24]  J. Robins.  A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .

[25]  James M Robins,et al.  Estimating Absolute Risks in the Presence of Nonadherence: An Application to a Follow-up Study With Baseline Randomization , 2010, Epidemiology.

[26]  J. Robins,et al.  Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/pds.1064 , 2022 .

[27]  Els Goetghebeur,et al.  Analysing compliance in clinical trials. , 2005, Statistical methods in medical research.

[28]  S. Piantadosi.  Clinical Trials : A Methodologic Perspective , 2005 .

[29]  Anna C. Balazs,et al.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.

[30]  D. Rubin,et al.  Intention‐to‐treat analysis and the goals of clinical trials , 1995, Clinical pharmacology and therapeutics.

[31]  Ian R White,et al.  Nonadherence to treatment protocol in published randomised controlled trials: a review , 2012, Trials.

[32]  Miguel A Hernán,et al.  Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials , 2016, Clinical trials.

[33]  Tyler J. VanderWeele,et al.  Sensitivity Analysis Without Assumptions , 2015, Epidemiology.